The Immunologic Functions of the Neonatal Fc Receptor for IgG
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Careful regulation of the body’s immunoglobulin G (IgG) and albumin concentrations is necessitated by the importance of their respective functions. As such, the neonatal Fc receptor (FcRn), as a single receptor, is capable of regulating both of these molecules and has become an important focus of investigation. In addition to these essential protection functions, FcRn possesses a number of other functions that are equally as critical and are increasingly coming to attention. During the very first stages of life, FcRn mediates the passive transfer of IgG from mother to offspring both before and after birth. In the adult, FcRn regulates the persistence of both IgG and albumin in the serum as well as the movement of IgG, and any bound cargo, between different compartments of the body via transcytosis across polarized cells. FcRn is also expressed by hematopoietic cells; consistent with this, FcRn regulates MHC class II presentation and MHC class I cross-presentation by dendritic cells. As such, FcRn plays an important role in immune surveillance throughout adult life. The increasing appreciation for FcRn in both homeostatic and pathological conditions is generating an intense interest in the potential for therapeutic modulation of FcRn binding to IgG and albumin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
FcRn: the neonatal Fc receptor comes of age
Roopenian, D. C., & Akilesh, S. (2007) · Nature Reviews Immunology · doi:10.1038/nri2155 · Cited by 2,346 · cited 1×
“appreciation for this interesting molecule; its function is now recognized to include a number of important activities that extend well beyond the neonatal life of rodents and to involve numerous different organ systems in a wide variety of animal systems [8].”
Self-citationBatf3 Deficiency Reveals a Critical Role for CD8α + Dendritic Cells in Cytotoxic T Cell Immunity
Hildner, K., Edelson, B. T., Purtha, W. E., Diamond, M., Matsushita, H., Kohyama, M., Calderon, B., Schraml, B. U., Unanue, E. R., Diamond, M. S., et al. (2008) · Science · doi:10.1126/science.1164206 · Cited by 2,081 · cited 4×
“However, the antigens generated for presentation by MHC class I molecules to CD8+ T cells are derived from the processing of cytosolic proteins by proteasomes and the transport of these nominal peptides into the endoplasmic reticulum (ER) by the transporter associated with antigen processing (TAP) [77, 78].”
InfluentialAn Fc receptor structurally related to MHC class I antigens
Simister, N. E., & Mostov, K. E. (1989) · Nature · doi:10.1038/337184a0 · Cited by 729 · cited 2×
“Originally, FcRn was shown to be responsible for the transfer of maternal IgG across the intestinal epithelium of neonatal rodents into the bloodstream to provide passively acquired immunity [3, 4].”
Chaudhury, C., Mehnaz, S., Robinson, J. M., Hayton, W. L., Pearl, D. K., Roopenian, D. C., & Anderson, C. L. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021829 · Cited by 640 · cited 1×
“Consistent with this, biochemical studies and cocrystallographic studies have revealed that FcRn has adopted a structure that allows it to function in the binding of both IgG and albumin [10, 11].”
Self-citationEngineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
Vaccaro, C., Zhou, J., Ober, R. J., & Ward, E. S. (2005) · Nature Biotechnology · doi:10.1038/nbt1143 · Cited by 407 · cited 1×
“Alternatively, antibodies and peptides have been developed that can block FcRn-IgG interactions and increase IgG catabolism [69–72].”
Crystal Structure at 2.8 Å of an FcRn/Heterodimeric Fc Complex
Martin, W. L., West, A. P., Gan, L., & Bjorkman, P. J. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00230-1 · Cited by 391
Leach, J. L., Sedmak, D. D., Osborne, J. M., Rahill, B., Lairmore, M. D., & Anderson, C. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3317 · Cited by 348
An IgG‐transporting Fc receptor expressed in the syncytiotrophoblast of human placenta
Simister, N. E., Story, C. M., Chen, H., & Hunt, J. S. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260718 · Cited by 332 · cited 2×
“Developmental regulation of FcRn exists, but to date it is known to occur only in the intestinal epithelium of the rodent, where FcRn expression is decreased 1000-fold at the time of weaning; and in the placenta, where FcRn functions to transport IgG from mother to fetus antenatally [2, 30, 31].”
Firan, M., Bawdon, R., Radu, C., Ober, R. J., Eaken, D., Antohe, F., Ghetie, V., & Ward, E. S. (2001) · International Immunology · doi:10.1093/intimm/13.8.993 · Cited by 330
Raghavan, M., Bonagura, V. R., Morrison, S. L., & Bjorkman, P. J. (1995) · Biochemistry · doi:10.1021/bi00045a005 · Cited by 317
Visualizing the site and dynamics of IgG salvage by the MHC class I-related receptor, FcRn
Ober, R. J., Martinez, C., Vaccaro, C., Zhou, J., & Ward, E. S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2021 · Cited by 314
Albumin Binding to FcRn: Distinct from the FcRn−IgG Interaction
Chaudhury, C., Brooks, C. L., Carter, D. C., Robinson, J. M., & Anderson, C. L. (2006) · Biochemistry · doi:10.1021/bi052628y · Cited by 290 · cited 4×
“Whereas FcRn binds IgG at a 2:1 ratio, it binds albumin with a stoichiometry of 1:1 [7, 10, 24, 25].”
InfluentialAn Engineered Human IgG1 Antibody with Longer Serum Half-Life
Hinton, P. R., Xiong, J. M., Johlfs, M. G., Tang, M. T., Keller, S., & Tsurushita, N. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.1.346 · Cited by 282
Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans
Ward, E. S. (2003) · International Immunology · doi:10.1093/intimm/dxg018 · Cited by 216 · cited 1×
“This pH-dependent binding is consistent with the predominance of FcRn within an intracellular locale—namely, in endosomes—and the interaction between FcRn and its ligands within an intracellular milieu [26–28].”
Montoyo, H. P., Vaccaro, C., Hafner, M., Ober, R. J., Mueller, W., & Ward, E. S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810796106 · Cited by 211 · cited 1×
“Although parenchymal cells such as the endothelium likely play a significant role in IgG protection—as shown by conditional deletion of FcRn in this cell type in vivo [61]—it is now clear that a significant fraction of IgG protection is due to the activities of hematopoietic cells.”
Antohe, F., Rădulescu, L., Gafencu, A., Gheţie, V., & Simionescu, M. (2001) · Human Immunology · doi:10.1016/s0198-8859(00)00244-5 · Cited by 175
Tzaban, S., Massol, R. H., Yen, E., Hamman, W., Frank, S. R., Lapierre, L. A., Hansen, S. H., Goldenring, J. R., Blumberg, R. S., & Lencer, W. I. (2009) · Journal of Cell Biology · doi:10.1083/jcb.200809122 · Cited by 169
Self-citationClaypool, S. M., Dickinson, B. L., Wagner, J. S., Johansen, F.-E., Venu, N., Borawski, J. A., Lencer, W. I., & Blumberg, R. S. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0832 · Cited by 139
Self-citationRaghavan, M., Gastinel, L. N., & Bjorkman, P. J. (1993) · Biochemistry · doi:10.1021/bi00084a037 · Cited by 108
Ellinger, I., Rothe, A., Grill, M., & Fuchs, R. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5330 · Cited by 39
Cited by
Antibody Structure and Function: The Basis for Engineering Therapeutics
Chiu, M. L., Goulet, D. R., Teplyakov, A., & Gilliland, G. L. (2019) · Antibodies · doi:10.3390/antib8040055 · Cited by 638
Lundquist, P., & Artursson, P. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.07.007 · Cited by 483
Albumin and its application in drug delivery
Sleep, D. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.993313 · Cited by 464
IgG Fc engineering to modulate antibody effector functions
Wang, X., Mathieu, M., & Brezski, R. J. (2018) · Protein & Cell · doi:10.1007/s13238-017-0473-8 · Cited by 356
“However, in the presence of 10% serum, the aglycosylated IgG1 had undetectable ADCP activity, suggesting that aglycosylated IgGs would have reduced effector function in circulation, which has serum IgG levels ranging from 10 to 20 mg/mL (Nesspor et al., 2012).”
BackgroundInfluentialThe first thousand days - intestinal microbiology of early life: Establishing a symbiosis
Wopereis, H., Oozeer, R., Knipping, K., Belzer, C., & Knol, J. (2014) · Pediatric Allergy and Immunology · doi:10.1111/pai.12232 · Cited by 352
Metadata
- Authors
- Rath, T., Kuo, T. T., Baker, K., Qiao, S.-W., Kobayashi, K., Yoshida, M., Roopenian, D., Fiebiger, E., Lencer, W. I., & Blumberg, R. S.
- Venue
- Journal of Clinical Immunology
- Published
- 2012-09-05
- Volume
- 33
- Issue
- S1
- Pages
- 9-17
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- OpenAlex
- W2064641208
- Cited by
- 156
- References
- 20
- FWCI
- 9.35
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.